Rapamycin Preferentially Inhibits Human IL-5+ Th2 Cell Proliferation via an mTORC1/S6 Kinase-1 Dependent Pathway
Publication date: Available online 3 December 2016 Source:Journal of Allergy and Clinical Immunology Author(s): Yuzhi Yin, Alyssa Mitson-Salazar, Daniel L. Wansley, Satya P. Singh, Calman Prussin
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου